Julie Smet

1.1k total citations
29 papers, 673 citations indexed

About

Julie Smet is a scholar working on Epidemiology, Immunology and Pharmacology. According to data from OpenAlex, Julie Smet has authored 29 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Julie Smet's work include Immunodeficiency and Autoimmune Disorders (7 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Julie Smet is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (7 papers), Pneumonia and Respiratory Infections (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Julie Smet collaborates with scholars based in Belgium, Netherlands and France. Julie Smet's co-authors include Françoise Mascart, Liliane Schandené, Koen Boussery, Mirjam van der Burg, Menno C. van Zelm, Jan Van Bocxlaer, Jacques J. M. van Dongen, Alina Ferster, Françoise Janssen and Brigitte Adams and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Julie Smet

25 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Smet Belgium 13 298 137 128 96 78 29 673
Yunfei An China 17 482 1.6× 180 1.3× 189 1.5× 57 0.6× 165 2.1× 105 1.1k
Leslie Obert United States 15 123 0.4× 101 0.7× 216 1.7× 27 0.3× 53 0.7× 29 770
Christine L. E. Siezen Netherlands 16 113 0.4× 65 0.5× 278 2.2× 94 1.0× 98 1.3× 19 810
Joaquín Borrás‐Blasco Spain 15 172 0.6× 57 0.4× 110 0.9× 135 1.4× 55 0.7× 61 618
S. Malik United Kingdom 13 279 0.9× 48 0.4× 248 1.9× 28 0.3× 85 1.1× 26 967
John G. Prichard United States 12 159 0.5× 36 0.3× 176 1.4× 44 0.5× 91 1.2× 27 882
Norbert Kiss Hungary 15 96 0.3× 73 0.5× 146 1.1× 20 0.2× 35 0.4× 90 750
Martha Hernandez‐Illas United States 12 109 0.4× 38 0.3× 85 0.7× 120 1.3× 101 1.3× 20 812
Susanne Marschner United States 22 160 0.5× 85 0.6× 119 0.9× 14 0.1× 140 1.8× 55 1.3k
Bradley P. Sullivan United States 19 245 0.8× 119 0.9× 238 1.9× 22 0.2× 11 0.1× 29 934

Countries citing papers authored by Julie Smet

Since Specialization
Citations

This map shows the geographic impact of Julie Smet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Smet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Smet more than expected).

Fields of papers citing papers by Julie Smet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Smet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Smet. The network helps show where Julie Smet may publish in the future.

Co-authorship network of co-authors of Julie Smet

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Smet. A scholar is included among the top collaborators of Julie Smet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Smet. Julie Smet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smet, Julie, et al.. (2025). Anti-Ku Antibodies: Clinical Associations, Organ Damage, and Prognostic Implications in Connective Tissue Diseases. International Journal of Molecular Sciences. 26(15). 7433–7433.
2.
Roufosse, Florence, et al.. (2025). Clinical value at baseline and follow-up of myeloperoxidase-antibodies in ANCA-associated vasculitis. Frontiers in Immunology. 16. 1649708–1649708.
3.
Geers, Caroline, et al.. (2024). Multisystemic Beryllium Disease: An Exceptional Case Revealed by a Urinary Tract Granulomatosis. International Journal of Molecular Sciences. 25(15). 8166–8166. 1 indexed citations
4.
Dauby, Nicolás, Evelyne Maillart, Jean‐François Fils, et al.. (2022). Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-6. Viral Immunology. 35(1). 60–70. 6 indexed citations
5.
Nagant, Carole, Julie Smet, Nicolás Dauby, et al.. (2020). A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer. International Journal of Infectious Diseases. 101. 342–345. 41 indexed citations
6.
Paepe, Peter De, Pieter Colin, Pieter Depuydt, et al.. (2015). Disulfiram inhibition of cyanide formation after acetonitrile poisoning. Clinical Toxicology. 54(1). 56–60. 3 indexed citations
7.
Schutter, Iris De, Anne Vergison, David Tuerlinckx, et al.. (2014). Pneumococcal Aetiology and Serotype Distribution in Paediatric Community-Acquired Pneumonia. PLoS ONE. 9(2). e89013–e89013. 18 indexed citations
8.
Tuerlinckx, David, Julie Smet, Iris De Schutter, et al.. (2013). Evaluation of a WHO-validated Serotype-specific Serological Assay for the Diagnosis of Pneumococcal Etiology in Children With Community-acquired Pneumonia. The Pediatric Infectious Disease Journal. 32(7). e277–e284. 7 indexed citations
9.
Smet, Julie, Kirsten Colpaert, Peter De Paepe, et al.. (2012). Switch from intravenous to enteral moxifloxacin in critically ill patients: A pilot study. Scandinavian Journal of Infectious Diseases. 44(11). 874–878. 4 indexed citations
10.
Boussery, Koen, Julie Smet, Pieter De Cock, et al.. (2011). Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems. British Journal of Clinical Pharmacology. 72(6). 990–996. 7 indexed citations
11.
Smet, Julie, Pieter Colin, Peter De Paepe, et al.. (2011). Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery. Journal of Antimicrobial Chemotherapy. 67(1). 226–229. 28 indexed citations
12.
Smet, Julie, Françoise Mascart, & Liliane Schandené. (2011). Are the reference values of B cell subpopulations used in adults for classification of common variable immunodeficiencies appropriate for children?. Clinical Immunology. 138(3). 266–273. 19 indexed citations
13.
Zelm, Menno C. van, Julie Smet, Mirjam van der Burg, et al.. (2011). Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation. Human Molecular Genetics. 20(9). 1854–1863. 21 indexed citations
14.
15.
Zelm, Menno C. van, Julie Smet, Brigitte Adams, et al.. (2010). CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency. Journal of Clinical Investigation. 120(4). 1265–1274. 266 indexed citations
16.
17.
Smet, Julie, Koen Boussery, Kirsten Colpaert, et al.. (2009). Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma. Journal of Chromatography B. 877(10). 961–967. 64 indexed citations
18.
Smet, Julie, Menno C. van Zelm, Mirjam van der Burg, et al.. (2008). Hypogammaglobulinemia associated with a novel CD19 mutation.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2 indexed citations
19.
Zelm, Menno C. van, Julie Smet, Françoise Mascart, et al.. (2008). Antibody-Deficiency and Acute Nephritic Syndrome in a Patient with Homozygous Disruption of the CD81 Gene. Blood. 112(11). 83–83. 3 indexed citations
20.
Hafraoui, Kaoutar, Michel Moutschen, Julie Smet, et al.. (2008). Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis. European Journal of Internal Medicine. 20(3). e62–e65. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunfei An Breakdown of academic impact, for papers by Leslie Obert Breakdown of academic impact, for papers by Christine L. E. Siezen Breakdown of academic impact, for papers by Joaquín Borrás‐Blasco Breakdown of academic impact, for papers by S. Malik Breakdown of academic impact, for papers by John G. Prichard Breakdown of academic impact, for papers by Norbert Kiss Breakdown of academic impact, for papers by Martha Hernandez‐Illas Breakdown of academic impact, for papers by Susanne Marschner Breakdown of academic impact, for papers by Bradley P. Sullivan
Rankless by CCL
2026